Modular Medical, Inc. (MODD)

NASDAQ: MODD · IEX Real-Time Price · USD
1.48
-0.12 (-7.63%)
Mar 30, 2023, 12:32 PM EDT - Market open
-7.63%
Market Cap 16.16M
Revenue (ttm) n/a
Net Income (ttm) -14.88M
Shares Out 10.93M
EPS (ttm) -1.48
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 7,059
Open 1.50
Previous Close 1.60
Day's Range 1.44 - 1.50
52-Week Range 1.45 - 5.43
Beta -3.15
Analysts Buy
Price Target 7.48 (+406.09%)
Earnings Date Feb 13, 2023

About MODD

Modular Medical, Inc., a development stage medical device company, focuses on the design, development, and commercialization of insulin pumps using technology to enhance pump adoption in the diabetes marketplace. The company is headquartered in San Diego, California. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1998
Employees 25
Stock Exchange NASDAQ
Ticker Symbol MODD
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for MODD stock is "Buy." The 12-month stock price forecast is $7.48, which is an increase of 406.09% from the latest price.

Price Target
$7.48
(406.09% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Modular Medical Provides Update on FDA Submission Strategy

SAN DIEGO, CA / ACCESSWIRE / January 25, 2023 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage insulin delivery technology company seeking to launch the ...

2 months ago - Accesswire

Modular Medical Announces Product Testing Update

SAN DIEGO, CA / ACCESSWIRE / November 28, 2022 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch th...

4 months ago - Accesswire

Modular Medical Announces Participation at Upcoming Investor Conferences

SAN DIEGO, CA / ACCESSWIRE / November 23, 2022 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch th...

4 months ago - Accesswire

Modular Medical Provides Product Update

SAN DIEGO, CA / ACCESSWIRE / October 3, 2022 / Modular Medical Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the n...

6 months ago - Accesswire

Dr. Anne Peters Joins the Modular Medical Advisory Board

Dr. Peters, a prominent diabetes clinician and clinical researcher, is a leading voice in the fight to bring diabetes technology and therapeutics to under-resourced communities SAN DIEGO, CA / ACCESSW...

8 months ago - Accesswire

Modular Medical Appoints Kevin Schmid as Chief Operating Officer

Schmid brings 40 years of experience in medical devices for drug delivery and diabetes management and a background in high-volume manufacturing SAN DIEGO, CA / ACCESSWIRE / July 26, 2022 / Modular Med...

8 months ago - Accesswire

Modular Medical to Present at LD Micro Invitational XII Investor Conference

SAN DIEGO, CA / ACCESSWIRE / June 2, 2022 / Modular Medical Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next...

10 months ago - Accesswire

Modular Medical to Present at Spring Into Action - Best Ideas Virtual Investor Conference on May 18, 2022

SAN DIEGO, CA / ACCESSWIRE / May 12, 2022 / Modular Medical, Inc. ("Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the next generation of e...

11 months ago - Accesswire

Modular Medical Announces $8 Million Registered Direct Offering

SAN DIEGO, CA / ACCESSWIRE / May 3, 2022 / Modular Medical, Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), today announced that it has entered into a securities purchase agreement with insti...

11 months ago - Accesswire

Modular Medical to Present at the Oppenheimer 32nd Annual Healthcare Conference

SAN DIEGO, CA / ACCESSWIRE / March 3, 2022 / Modular Medical Inc. (the "Company" or "Modular Medical") (NASDAQ:MODD), a development stage, insulin delivery technology company seeking to launch the nex...

1 year ago - Accesswire

Modular Medical Appoints James "Jeb" Besser as Chief Executive Officer

Lynn Vos to remain on board of directors Besser brings 25 years of experience in life sciences, technology, capital markets Company reaffirms timeline for 510(k) submission of MODD1 insulin pump to FD...

1 year ago - Accesswire

Modular Medical Announces Pricing of $15 Million Public Offering and Uplisting to the Nasdaq Capital Market

SAN DIEGO, CA / ACCESSWIRE / February 10, 2022 / Modular Medical, Inc., (NASDAQ:MODD) (the "Company" or "Modular Medical"), a development-stage insulin pump company focused on providing insulin delive...

1 year ago - Accesswire

Steven G. Felsher and Philip B. Sheibley Appointed to Board of Directors of Modular Medical, Inc.

SAN DIEGO, CA / ACCESSWIRE / November 29, 2021 / Modular Medical, Inc. (the "Company" or "Modular Medical") (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery...

1 year ago - Accesswire

Modular Medical, Inc. Announces Reverse Stock Split in Connection with Application for Uplisting on the NASDAQ Capital Market

SAN DIEGO, CA / ACCESSWIRE / November 26, 2021 / Modular Medical, Inc. (the "Company") (OTCQB:MODD), a development-stage insulin pump company focused on providing insulin delivery without complexity t...

1 year ago - Accesswire